Palo Alto Investors »

Edwards Lifesciences shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 40k 65.99

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Alnylam Pharmaceuticals (ALNY)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Anaptysbio Inc Common (ANAB)
Sarepta Therapeutics (SRPT)
Alkermes SHS (ALKS)
Ptc Therapeutics I (PTCT)
Align Technology (ALGN)

View all positions for Palo Alto Investors

Top funds holding Edwards Lifesciences

Vanguard Group
BlackRock
Wellington Management Company
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Fisher Investments
Jpmorgan Chase & Co
Brown Advisory Holdings Incorporated
Jennison Associates
Investec Asset Management
Alliancebernstein
Deutsche Bank Aktiengesellschaft
Ubs Global Asset Management Americas
Legal & General Group

View all funds holding Edwards Lifesciences